MediPharm Labs Corp. (OTCMKTS:MEDIF – Get Free Report) was the target of a large increase in short interest during the month of August. As of August 14th, there was short interest totaling 17,636 shares, an increase of 1,668.9% from the July 30th total of 997 shares. Based on an average daily trading volume, of 132,170 shares, the short-interest ratio is presently 0.1 days.
MediPharm Labs Price Performance
Shares of OTCMKTS:MEDIF opened at $0.06 on Wednesday. MediPharm Labs has a 52-week low of $0.04 and a 52-week high of $0.08. The stock’s 50-day simple moving average is $0.05 and its two-hundred day simple moving average is $0.05.
About MediPharm Labs
MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.
The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.
See Also
- Five stocks we like better than MediPharm Labs
- Tariffs Are Back in Focus: 3 Stocks With a Home-Field Advantage
- Marzetti Stock Confirms Reversal on Earnings Strength, Dividend Growth
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
